Rockville biotech begins human trials on lung cancer drug
October 26th, 2006
EntreMed has launched a first round of human trials on lung cancer patients for a drug already in clinical tests to battle other forms of cancer.
The Rockville company is starting Phase I trials of MKC-1, its small-molecule drug to treat lung cancer — the same drug it began testing in Phase I for leukemia one month ago and in Phase II trials for advanced breast cancer 10 months ago.